Bio-Rad Laboratories, Inc. (N:BIO)

Business Focus: Medical Equipment, Supplies & Distribution

Competitors with Recent Insider Filings
Tandem Diabetes Care (OQ:TNDM)
DexCom (OQ:DXCM)
Neogen (OQ:NEOG)
Latest 10 SEC filings (by transaction date) for BIO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 20th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 16/19 May 16/19 Ernst Timothy S Direct Ownership Bio-Rad A Common Stock S - Open market or private sale -309 $299.31
May 16/19 May 16/19 Ernst Timothy S Direct Ownership Bio-Rad A Common Stock S - Open market or private sale -192 $299.12
May 16/19 May 15/19 Ernst Timothy S Direct Ownership Bio-Rad A Common Stock S - Open market or private sale -345 $290.00
May 15/19 May 15/19 Magni Giovanni Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -3,500  
May 15/19 May 15/19 Magni Giovanni Direct Ownership Bio-Rad A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,803 $290.63
May 15/19 May 15/19 Magni Giovanni Direct Ownership Bio-Rad A Common Stock M - Exercise or conversion exempt under rule 16b-3 3,500 $74.27
May 13/19 May 13/19 Schwartz Norman D Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -37,000  
May 13/19 May 13/19 Schwartz Norman D Direct Ownership Bio-Rad B Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -22,833 $296.28
May 13/19 May 13/19 Schwartz Norman D Direct Ownership Bio-Rad B Common Stock M - Exercise or conversion exempt under rule 16b-3 37,000 $75.38
Apr 30/19 Apr 29/19 Last Andrew J. Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 5,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for BIO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET May 20th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 16/19 May 16/19 Ernst Timothy S Direct Ownership Bio-Rad A Common Stock S - Open market or private sale -309 $299.31
May 16/19 May 16/19 Ernst Timothy S Direct Ownership Bio-Rad A Common Stock S - Open market or private sale -192 $299.12
May 16/19 May 15/19 Ernst Timothy S Direct Ownership Bio-Rad A Common Stock S - Open market or private sale -345 $290.00
May 15/19 May 15/19 Magni Giovanni Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -3,500  
May 15/19 May 15/19 Magni Giovanni Direct Ownership Bio-Rad A Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -1,803 $290.63
May 15/19 May 15/19 Magni Giovanni Direct Ownership Bio-Rad A Common Stock M - Exercise or conversion exempt under rule 16b-3 3,500 $74.27
May 13/19 May 13/19 Schwartz Norman D Direct Ownership Non-Qualified Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -37,000  
May 13/19 May 13/19 Schwartz Norman D Direct Ownership Bio-Rad B Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -22,833 $296.28
May 13/19 May 13/19 Schwartz Norman D Direct Ownership Bio-Rad B Common Stock M - Exercise or conversion exempt under rule 16b-3 37,000 $75.38
Apr 30/19 Apr 29/19 Last Andrew J. Direct Ownership Non-Qualified Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 5,000  
Sign up for a free account or login above to see all SEC filings within the past 6 months.
Sign up for a free account or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $BIO

StockTwits